Drug Discovery World
AUGUST 7, 2023
Research published in Science shows that a naturally occurring bacterium discovered by GSK scientists – Delftia tsuruhatensis Tres Cantos 1 (TC1) – could be the basis for new anti-malarial interventions. “We hope to provide a viable solution that can be readily adopted in field settings.” ovale and P. malariae in addition to P.
Pharmaceutical Technology
OCTOBER 6, 2022
Therapyx will develop and manufacture the IL-12-containing microspheres in the vaccine called GneX12. A sexually transmitted disease, gonorrhoea is caused by the NG bacteria. Additionally, antibiotic resistance is very prevalent for the NG bacterium. This trial will evaluate the safety of the vaccine and generate efficacy data.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pfizer
JANUARY 27, 2023
Trachoma is a neglected tropical disease (NTD) caused by the bacterium Chlamydia trachomatis. Disclosure Notice The information contained in this statement is as of January [30], 2023. This statement contains forward-looking statements about the donation of the one billionth Zithromax dose as part of the WHO recommended S.A.F.E.
The Pharma Data
NOVEMBER 26, 2020
Founded in February 2014, 4D pharma is a world leader in the development of Live Biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacterium, that is applicable to the prevention, treatment or cure of a disease.? For more information, refer to [link].
XTalks
AUGUST 2, 2023
It contains the antiviral medications nirmatrelvir and ritonavir. 2) Botox Therapeutic/Cosmetic Botox, or botulinum neurotoxin, is a neurotoxic protein produced by the Clostridium botulinum bacteria. Xgeva, like Prolia, contains the active ingredient denosumab, but the intended use, dose and treatment interval differ.
Expert insights. Personalized for you.
52 
Let's personalize your content